An antagonistic strain of Streptococcus faecium was isolated from human feces, and it displayed a marked inhibition of bifidobacteria on agar plates. In liquid culture this isolate produced an antibacterial substance that can be partially purified by ammonium sulfate precipitation followed by gel filtration and ionexchange chromatography. Its activity was assayed by the inhibition of growth of Bifidobacterium longum. The substance was sensitive to digestion by proteolytic enzymes and a-amylase, but was resistant to treatment with 6 M urea, dithiothreitol, 2-mercaptoethanol, ethyl ether, chloroform, and lysozyme. It was also stable to heating at 1000C for 60 min. Its molecular weight was estimated to be about 50,000 by gel filtration.
Bacterial antagonism has long been recognized and usually attributed to such products as antibiotics, bacteriocins, metabolic wastes, and bacteriophages. This phenomenon has sometimes been observed in the course of ecological studies of microflora in human feces. During the studies of intestinal microflora, Hoogkamp-Korstanje et al. found Streptococcus faecium antagonistic to bifidobacteria, but they failed to demonstrate the inhibitory substance in supernatant of culture fluids (5) . Various strains of S. faecium have shown to produce bacteriocins active against a wide range of bacteria (1, 3, 6, 10) , but little is known about antibacterial substance in streptococci that is antagonistic to bifidobacteria.
This report deals with the isolation and preliminary characterization of the antibacterial substance produced by a human fecal isolate of S. faecium antagonistic to bifidobacteria.
MATERIALS AND METHODS
Bacterial strains and cultivations. An inhibitorproducing coccus isolated from feces of a healthy adult was identified as Enterococcus (group D Streptococcus) on the basis of its Gram-staining reaction, microscopic morphology, growth in the presence of 6.5% NaCl, growth at 450C, growth at pH 9.6, and lack of catalase activity. The isolate was further characterized as S. faecium by virtue of its fermentation of lactose, mannitol, arabinose, and melibiose; nonfermentation of sorbitol, glycerol, and melezitose; reduction of methylene blue; nonreduction of tetrazolium; nonhemolysis on 5% human and horse blood agar plates; and survival at 60°C for 30 min. A wide variety of organisms listed in Table 1 tions and were tested for susceptibility to inhibitory action of the isolated coccus.
The organisms were all grown anaerobically at 370C on glucose-blood-liver (BL) agar medium, of which the composition was described elsewhere (8) . Liquid medium was provided by removing agar from BL agar medium and by substituting Fildes solution for blood (4) .
Assay of antibacterial substance. A 0.1-ml amount of the broth culture of indicator strain (Bifidobacterium longum) was pipetted onto the surface of plates and was spread to obtain a uniform bacterial lawn. After drying the surface of the agar medium at 370C for 30 min, a loopful drop of twofold dilutions containing antibacterial substance was spotted on the surface of each plate. By this technique, the inoculum of the indicator strain was kept at a constant size (approximately 107 cells per 0.1 ml). After incubation at 370C overnight, the plates were examined for inhibition zones.
Molecular weight estimations. The molecular weight of the antibacterial substance was estimated by gel filtration on a Sephadex G-75 (Pharmacia Fine Chemicals, Uppsala, Sweden) column (3 by 45 cm). Bovine serum albumin (molecular weight, 67,000), ovalbumin (molecular weight, 45,000), and lysozyme (molecular weight, 14,400) were used as reference proteins to calibrate the column. Bovine serum albumin and ovalbumnin were obtained from Wako Pure Chemical Industries, Osaka, Japan, and lysozyme was from Seikagaku Kogyo Co., Tokyo, Japan.
Enzymes and chemicals. Various reagents were used to treat the partially purified preparation in an effort to define the nature of the antibacterial substance. Urea, dithiothreitol, 2-mercaptoethanol, ethyl ether, chloroforn, trypsin, and a-amylase were obtained from Wako Pure Chemical Industries, Osaka, Japan; papain was from E. Merk AG, Darmstadt, Germany; protease (type V) was from Sigma Chemical Co., St. Louis, Mo.; and pronase E was from Kaken Chemical Co., Tokyo, Japan. The reagent-treated preparation was then measured for activity. Detection of glycoprotein. By using p-dimethylaminobenzaldehyde (Wako Pure Chemical Industries, Osaka, Japan) reagent, the hydrolysate of the antibacterial substance was tested by the method of Morgan and Elson (9) .
RESULTS
Spectrum of antagonistic action. Various gram-positive and gram-negative bacteria were tested for susceptibility to inhibition by the isolated coccus. Antagonistic action was determined in cross-streaks of the isolate against horizontal streaks of. organisms to be tested on BL agar plates. The isolate displayed a marked inhibition of bifidobacteria on agar plates (Fig. 1) . It was also antagonistic to some lactobacilli, anaerobic gram-positive cocci, and Bacteroides melaninogenicus (Table 1) , but no streptococci, with the exception of Streptococcus morbillorum, were susceptible.
Purification of antibacterial substance. BL broth (2,000 ml) was inoculated with 1% inoculum obtained from a 18-h culture of the antagonistic isolate. After incubation at 37°C for 18 h, the bacterial cells were removed by centrifugation at 10,000 rpm for 30 min. Solid ammonium sulfate was added to the supernatant fluid with constant stirring until the solution was 50% saturated. The precipitate was collected by centrifugation at 10,000 rpm for 30 min and discarded. Ammonium sulfate was added again to the supernatant fluid to bring it to 80% saturation, and the resulting precipitate was collected by centrifugation at 10,000 rpm for 30 min. This precipitate was dissolved in 80 ml of 0.05 M tris(hydroxymethyl)aminomethane (Tris)-hydrochloride buffer (pH 7.8) and dialyzed in the cold against the same buffer for 18 h.
After filtration through a 450-nm pore size membrane filter (Millipore Corp., Bedford, Mass.), the solution of antibacterial substance was placed on a Sephadex G-75 column (3 by 45 cm) previously equilibrated with 0.05 M Trishydrochloride buffer (pH 7.8). The column was eluted with the same buffer at a flow rate of 35 ml/h. Effluent fractions of 5 ml were collected, monitored for absorbance at 280 nm, and assayed for antibacterial activity (Fig. 2) .
The active fractions were pooled and applied to a column (1.5 by 30 cm) of diethylaminoethylSephadex A-50 (Pharmacia Fine Chemicals, Uppsala, Sweden), previously equilibrated with 0.05 M Tris-hydrochloride buffer (pH 7.8). The antibacterial substance was eluted as a single peak with a linear gradient (0 to 0.5 M NaCl with the same buffer) at a flow rate of 35 ml/h (Fig. 3) . These procedures are summarized in Table 2 .
The resulting preparation of antibacterial substance was stored at 40C and used for further characterization.
The purity of antibacterial substance was examined by high-performance liquid chromatography with a ConstaMetric IIG (Milton Roy Co., Riviera Beach, Fla.) with a Shodex OHpak B-804 (Showa Denko, Tokyo, Japan) column and a model 1202 SpectroMonitor II (Milton Roy Co., Riviera Beach, Fla.) (Fig. 4 and 5) .
Properties of antibacterial substance. An estimation of the chemical nature of the antibacterial substance was obtained by testing its sensitivity to various reagents (Table 3) . Partially purified preparation of antibacterial substance was sensitive to digestion by proteolytic enzymes and a-amylase. Incubation with either papain (1 mg/ml), pronase (1 mg/ml), protease (1 mg/ml), trypsin (2 mg/ml), or a-amylase (5 mg/ml) showed loss of activity, the titer decreasing from 32 to 16 or 8 at 37°C for 60 min.
Urea (6 M), dithiothreitol (3 x 10-' M), 2-mercaptoethanol (5 x 10-3 M), ethyl ether (50%), chloroform (50%), and lysozyme (1 mg/ml) had no effect on its activity. The substance was particularly stable to heating, with no apparent decrease in activity on heating at 100°C for 60 min.
The antibacterial substance revealed a positive reaction in the Morgan-Elson test.
This substance appeared to have a molecular weight of about 50,000, as determined by its position of elution from the Sephadex G-75 column relative to the standard marker proteins.
DISCUSSION
The present investigation has shown that antagonistic action of S. faecium against bifidobacteria is due to an antibacterial substance. Some strains of S. faecium have been shown to produce bacteriocins. Pleceas examined 28 strains VOL. 18, 1980 11) observed that S. faecium displayed a broad spectrum of activity against gram-positive bacteria, in contrast to the classical description of bacteriocins as being active against other strains of the same or closely related species. The antagonistic action of our isolate is effective against some strains of lactobacilli and Bacteroides melaninogenicus as well as against bifidobacteria. However, the overall spectrum of the antibacterial activity that we investigated was not always comparable to the bacterial species surveyed by Hoogkamp-Korstanje et al. found a strain of S. faecium antagonistic to bifidobacteria on agar plates, but they failed to demonstrate the inhibitory substance in supernatant of culture fluids (5) . Although no culture supernatant had inhibitory activity when tested directly in our studies, the active substance was precipitated with ammonium sulfate largely within the range of 50 to 80% saturated. The substance that we isolated seems to lack hydrophobic bonds and disulfide was trypsin sensitive and had a molecular weight of about 10,000, and another type was typsin resistant and had a molecular weight of above 100,000 (7). These lead us to speculate that S. faecium includes various strains which produce 'different active substances.
The bacteriocinogeny of S. faecium strain El could be eliminated in the presence of acridine orange, proflavin, or trypaflavin (2). Any definitive conclusion with regard to our antibacterial substance as a bacteriocin must wait until its production is demonstrated to be controlled by a plasmid gene.
